Brigham Young University Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2011
NCT02029521
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Brigham Young Univeristy

Active Ingredients

Drugs in Other Trials (1)

glutathione (Furadantin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1